NBIX logo

Neurocrine Biosciences (NBIX) Total Assets

Annual Total Assets

$3.25 B
+$882.70 M+37.27%

31 December 2023

NBIX Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Assets

$3.54 B
+$230.00 M+6.96%

30 September 2024

NBIX Quarterly Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NBIX Total Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+37.3%+24.1%
3 y3 years+87.4%+75.2%
5 y5 years+227.4%+199.6%

NBIX Total Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+87.4%at high+76.3%
5 y5 yearsat high+227.4%at high+199.6%
alltimeall timeat high+4491.2%at high>+9999.0%

Neurocrine Biosciences Total Assets History

DateAnnualQuarterly
Sept 2024
-
$3.54 B(+7.0%)
June 2024
-
$3.31 B(-4.8%)
Mar 2024
-
$3.47 B(+6.8%)
Dec 2023
$3.25 B(+37.3%)
$3.25 B(+14.2%)
Sept 2023
-
$2.85 B(+9.0%)
June 2023
-
$2.61 B(+10.7%)
Mar 2023
-
$2.36 B(-0.4%)
Dec 2022
$2.37 B(+14.3%)
$2.37 B(+10.5%)
Sept 2022
-
$2.14 B(+6.9%)
June 2022
-
$2.01 B(-6.5%)
Mar 2022
-
$2.14 B(+3.5%)
Dec 2021
$2.07 B(+19.5%)
$2.07 B(+2.7%)
Sept 2021
-
$2.02 B(+3.1%)
June 2021
-
$1.96 B(+6.0%)
Mar 2021
-
$1.85 B(+6.4%)
Dec 2020
$1.73 B(+32.8%)
$1.73 B(+15.4%)
Sept 2020
-
$1.50 B(-0.9%)
June 2020
-
$1.52 B(+11.3%)
Mar 2020
-
$1.36 B(+4.3%)
Dec 2019
$1.31 B(+31.5%)
$1.31 B(+10.7%)
Sept 2019
-
$1.18 B(+10.6%)
June 2019
-
$1.07 B(+11.4%)
Mar 2019
-
$957.72 M(-3.6%)
Dec 2018
$993.15 M(+21.5%)
$993.15 M(+6.4%)
Sept 2018
-
$933.75 M(+11.0%)
June 2018
-
$841.32 M(+4.3%)
Mar 2018
-
$806.36 M(-1.4%)
Dec 2017
$817.59 M(+123.9%)
$817.59 M(+5.8%)
Sept 2017
-
$772.50 M(+2.4%)
June 2017
-
$754.09 M(+160.6%)
Mar 2017
-
$289.36 M(-20.7%)
Dec 2016
$365.09 M(-23.1%)
$365.09 M(-8.5%)
Sept 2016
-
$399.16 M(-7.1%)
June 2016
-
$429.84 M(-6.4%)
Mar 2016
-
$459.33 M(-3.3%)
Dec 2015
$474.79 M(+95.4%)
$474.79 M(-3.6%)
Sept 2015
-
$492.44 M(-3.7%)
June 2015
-
$511.20 M(-3.1%)
Mar 2015
-
$527.78 M(+117.2%)
Dec 2014
$243.03 M(+57.1%)
$243.03 M(-5.7%)
Sept 2014
-
$257.75 M(-4.4%)
June 2014
-
$269.54 M(-3.5%)
Mar 2014
-
$279.30 M(+80.6%)
Dec 2013
$154.68 M(-21.1%)
$154.68 M(-6.8%)
Sept 2013
-
$165.97 M(-5.1%)
June 2013
-
$174.81 M(-5.0%)
Mar 2013
-
$183.92 M(-6.2%)
Dec 2012
$195.98 M(+41.6%)
$195.98 M(+1.4%)
Sept 2012
-
$193.25 M(-4.4%)
June 2012
-
$202.09 M(-3.8%)
Mar 2012
-
$210.14 M(+51.9%)
Dec 2011
$138.37 M(-4.2%)
$138.37 M(-7.2%)
Sept 2011
-
$149.03 M(+17.0%)
June 2011
-
$127.41 M(-4.9%)
Mar 2011
-
$134.00 M(-7.2%)
Dec 2010
$144.42 M
$144.42 M(-3.7%)
Sept 2010
-
$149.93 M(-3.3%)
DateAnnualQuarterly
June 2010
-
$155.04 M(+94.1%)
Mar 2010
-
$79.88 M(+12.8%)
Dec 2009
$70.82 M(-40.1%)
$70.82 M(-6.7%)
Sept 2009
-
$75.91 M(-12.6%)
June 2009
-
$86.87 M(-14.0%)
Mar 2009
-
$101.03 M(-14.5%)
Dec 2008
$118.18 M(-57.3%)
$118.18 M(-43.1%)
Sept 2008
-
$207.73 M(-7.9%)
June 2008
-
$225.67 M(-7.5%)
Mar 2008
-
$243.88 M(-11.8%)
Dec 2007
$276.65 M(-29.0%)
$276.65 M(-12.9%)
Sept 2007
-
$317.50 M(-7.1%)
June 2007
-
$341.86 M(-6.0%)
Mar 2007
-
$363.71 M(-6.7%)
Dec 2006
$389.68 M(-19.3%)
$389.68 M(-3.6%)
Sept 2006
-
$404.13 M(-8.7%)
June 2006
-
$442.54 M(-7.3%)
Mar 2006
-
$477.40 M(-1.2%)
Dec 2005
$483.12 M(-7.0%)
$483.12 M(-3.6%)
Sept 2005
-
$500.97 M(+5.4%)
June 2005
-
$475.51 M(-2.2%)
Mar 2005
-
$486.37 M(-6.3%)
Dec 2004
$519.22 M(-6.4%)
$519.22 M(-6.0%)
Sept 2004
-
$552.62 M(+1.1%)
June 2004
-
$546.48 M(-5.3%)
Mar 2004
-
$577.27 M(+4.0%)
Dec 2003
$554.96 M(+108.2%)
$554.96 M(+0.5%)
Sept 2003
-
$552.40 M(+48.2%)
June 2003
-
$372.76 M(+2.7%)
Mar 2003
-
$363.04 M(+36.2%)
Dec 2002
$266.54 M(-23.0%)
$266.54 M(-10.7%)
Sept 2002
-
$298.64 M(-4.1%)
June 2002
-
$311.37 M(-5.2%)
Mar 2002
-
$328.29 M(-5.2%)
Dec 2001
$346.35 M(+86.2%)
$346.35 M(+94.6%)
Sept 2001
-
$177.95 M(+8.8%)
June 2001
-
$163.62 M(-5.3%)
Mar 2001
-
$172.84 M(-7.1%)
Dec 2000
$185.96 M(+70.3%)
$185.96 M(+93.2%)
Sept 2000
-
$96.26 M(-1.7%)
June 2000
-
$97.91 M(-8.0%)
Mar 2000
-
$106.40 M(-2.6%)
Dec 1999
$109.20 M(+35.7%)
$109.20 M(+59.9%)
Sept 1999
-
$68.30 M(-3.3%)
June 1999
-
$70.60 M(-5.4%)
Mar 1999
-
$74.60 M(-7.3%)
Dec 1998
$80.50 M(-12.4%)
$80.50 M(-7.4%)
Sept 1998
-
$86.90 M(+4.1%)
June 1998
-
$83.50 M(-5.4%)
Mar 1998
-
$88.30 M(-3.9%)
Dec 1997
$91.90 M(+17.8%)
$91.90 M(+8.2%)
Sept 1997
-
$84.90 M(+1.1%)
June 1997
-
$84.00 M(+1.3%)
Mar 1997
-
$82.90 M(+6.3%)
Dec 1996
$78.00 M
$78.00 M(+8.0%)
Sept 1996
-
$72.20 M(-1.6%)
June 1996
-
$73.40 M(+161.2%)
Mar 1996
-
$28.10 M

FAQ

  • What is Neurocrine Biosciences annual total assets?
  • What is the all time high annual total assets for Neurocrine Biosciences?
  • What is Neurocrine Biosciences annual total assets year-on-year change?
  • What is Neurocrine Biosciences quarterly total assets?
  • What is the all time high quarterly total assets for Neurocrine Biosciences?
  • What is Neurocrine Biosciences quarterly total assets year-on-year change?

What is Neurocrine Biosciences annual total assets?

The current annual total assets of NBIX is $3.25 B

What is the all time high annual total assets for Neurocrine Biosciences?

Neurocrine Biosciences all-time high annual total assets is $3.25 B

What is Neurocrine Biosciences annual total assets year-on-year change?

Over the past year, NBIX annual total assets has changed by +$882.70 M (+37.27%)

What is Neurocrine Biosciences quarterly total assets?

The current quarterly total assets of NBIX is $3.54 B

What is the all time high quarterly total assets for Neurocrine Biosciences?

Neurocrine Biosciences all-time high quarterly total assets is $3.54 B

What is Neurocrine Biosciences quarterly total assets year-on-year change?

Over the past year, NBIX quarterly total assets has changed by +$686.80 M (+24.11%)